Yersinia pestis (Plague)

Yersinia pestis is the bacterium that causes plague — the illness history remembers as the “Black Death.” It is one of the most consequential microbes in human history, blamed for three great pandemics and, by some estimates, the deaths of hundreds of millions of people over the centuries. That reputation makes plague sound like something out of the distant past, but it is not. Yersinia pestis still circulates today among wild rodents and their fleas on several continents, and every year it infects people — including a handful in the rural western United States and larger numbers in places such as Madagascar. The single most important thing to know is this: plague is a treatable disease when it is caught early. Prompt antibiotics cure most patients. The danger lies in delay — when a rare, unexpected illness is not recognized in time. This page explains what the bacterium is, how it spreads, the three forms plague can take, and how it is diagnosed, treated, and prevented, in plain language and without sensationalism.

Table of Contents

  1. Overview: The Bacterium Behind the Black Death
  2. A Brief History — and Why Plague Isn’t Only History
  3. The Bacterium: A “Safety-Pin” Coccobacillus
  4. How Plague Spreads: Rodents, Fleas, and People
  5. The Three Forms of Plague
  6. Who’s Most at Risk
  7. Diagnosis: Speed Matters
  8. Treatment: Curable When Caught Early
  9. Prevention
  10. Plague as a Select Agent
  11. The Honest Bottom Line
  12. Research Papers
  13. Connections
  14. Featured Videos

Overview: The Bacterium Behind the Black Death

Yersinia pestis is a small bacterium that lives naturally in wild rodents and is passed among them — and occasionally to humans — by fleas. When it infects a person, the result is plague. Depending on where the bacteria take hold in the body, plague appears in three main forms: a swollen, painful lymph node (bubonic), a bloodstream infection (septicemic), or a lung infection (pneumonic). All three are serious, and all three were, for most of human history, very often fatal.

What changed everything was the twentieth-century arrival of antibiotics. Before them, plague ran its natural course and killed a large fraction of those it touched. Today, the same infection that terrified medieval cities can, in most cases, be cured with a course of ordinary antibiotics — if it is recognized and treated quickly. That “if” is the whole story of modern plague. The bacterium has not become gentler; medicine has become better. The remaining tragedy is almost always one of delay: a diagnosis missed because plague is rare and unexpected, or care sought too late.

Plague is a notifiable disease everywhere it occurs. A suspected case is reported to public health authorities immediately, both to protect the patient’s contacts and to track the animals and fleas that keep the bacterium alive in the wild.

A Brief History — and Why Plague Isn’t Only History

Plague has swept the world in three great pandemics, and knowing them helps explain why the disease looms so large in our imagination.

Plague is not only history. Yersinia pestis never disappeared — it simply retreated into wildlife. It remains present in wild rodent populations across parts of the Americas, Africa, and Asia. Human cases still occur every year. In the United States there are on average around seven reported cases annually, almost all in the rural West — states such as New Mexico, Arizona, Colorado, and California. Globally, the country reporting the most cases in recent decades is Madagascar, which experienced a large outbreak including pneumonic plague in 2017; the Democratic Republic of the Congo and Peru also report regular cases. Plague is rare, but it is real and ongoing.

The Bacterium: A “Safety-Pin” Coccobacillus

Yersinia pestis is a Gram-negative coccobacillus — a short, plump rod, shaped somewhere between a sphere and a rod, that stains pink rather than purple under the Gram stain. It belongs to the same broad bacterial family as many common gut organisms, but it is a specialist, exquisitely adapted to move between rodents and fleas.

Its most famous laboratory feature is its bipolar staining. When stained with certain dyes (such as Wayson, Giemsa, or Wright stain), the bacterium takes up color most strongly at its two ends and stays pale in the middle. Under the microscope this gives each cell the look of a “closed safety pin,” a classic clue that can point an alert laboratory toward the diagnosis.

A few other features matter for understanding the disease:

How Plague Spreads: Rodents, Fleas, and People

Plague is fundamentally a disease of rodents and their fleas. Humans are accidental, dead-end hosts most of the time — caught up in a cycle that mostly plays out among wild animals.

The natural cycle. The bacterium circulates quietly among wild rodents — in North America that means animals such as rats, prairie dogs, ground squirrels, rock squirrels, chipmunks, and wood rats — and the fleas that feed on them. Some rodents are relatively resistant and act as a long-term reservoir. Trouble starts when the bacterium reaches a highly susceptible species: an outbreak can cause a dramatic rodent die-off. When the host animals die, their hungry fleas leave the cooling bodies in search of a new blood meal — and any warm-blooded creature nearby, including a person or a pet, may do.

The flea’s role. A flea becomes infectious after feeding on a bacteremic animal. In some fleas the bacteria form a sticky mass that partially blocks the insect’s gut; a “blocked” flea, unable to feed properly, bites repeatedly and regurgitates bacteria into each new wound — an efficient way to seed infection.

How people catch it. There are three main routes:

The Three Forms of Plague

Plague takes three main clinical forms depending on where the bacteria establish themselves. They can overlap or progress from one to another, and recognizing them — especially the fast-moving lung form — is what makes the difference between recovery and disaster.

Bubonic plague — the flea-bite form

This is the most common form and the one linked most directly to flea bites. After an incubation of roughly two to eight days, the illness begins suddenly: high fever, chills, headache, and a wrung-out feeling of exhaustion. Within a day or so the hallmark appears — a bubo, an intensely painful, swollen, tender lymph node, most often in the groin, armpit, or neck, in the drainage path of the fleabite. The bubo can grow to the size of an egg and is so tender that patients guard the area. Treated promptly, bubonic plague usually responds well. Left untreated, it can spill into the bloodstream and become septicemic or spread to the lungs.

Septicemic plague — the bloodstream form

Septicemic plague means the bacteria are multiplying in the blood. It may arise on its own (without an obvious bubo) or as a complication of untreated bubonic plague. Symptoms include high fever, chills, profound weakness, abdominal pain, and, as the infection overwhelms the body, dangerously low blood pressure and shock. The bloodstream infection can trigger widespread clotting and bleeding, and it can starve the small vessels of the fingers, toes, nose, and lips of blood — causing the tissue to die and turn black (gangrene). This blackening of the extremities is one of the images that helped give the medieval pandemic its name, the “Black Death.” Septicemic plague is a medical emergency with a high fatality rate if not treated fast.

Pneumonic plague — the lung form

Pneumonic plague is infection of the lungs, and it is the most dangerous form for two reasons. First, it moves with frightening speed: after a short incubation (as little as one to four days for the inhaled, or “primary,” form), it causes a rapidly worsening pneumonia with fever, cough, chest pain, difficulty breathing, and watery or bloody sputum. Without antibiotics started very early — generally within about a day of the first symptoms — it is almost uniformly fatal. Second, pneumonic plague is the only form that spreads directly from person to person, through respiratory droplets in the air. That combination — fast, lethal, and contagious — is why pneumonic plague drives the strictest precautions and the greatest public-health concern.

Who’s Most at Risk

Plague is uncommon, and most people have essentially no exposure. Risk is concentrated among those who spend time where the bacterium lives in wildlife, and those who come into contact with sick animals. The main risk factors are:

Being in a high-risk setting does not mean infection is likely — it simply means plague belongs on the list of possibilities if a sudden, severe febrile illness follows a plausible exposure.

Diagnosis: Speed Matters

Because plague can move so quickly, clinical suspicion is the most important diagnostic tool. A doctor who considers plague early — in a patient with a sudden high fever and a painful bubo, or a fast-progressing pneumonia, together with a plausible exposure in an endemic area — can start life-saving treatment before laboratory confirmation ever comes back. Waiting for certainty can cost a patient their life.

Laboratory confirmation uses samples taken from wherever the infection is active:

A critical safety point: warn the laboratory. If plague is suspected, the clinician must alert the lab in advance. Yersinia pestis is hazardous to handle — it can infect laboratory workers through aerosols — and it is a Tier 1 Select Agent (a category of dangerous pathogens with bioterrorism potential). Advance warning lets the laboratory apply the right biosafety precautions and route the specimen to a specialized public-health laboratory for confirmation, rather than risk an unsuspecting technician opening a plague culture on an open bench.

Treatment: Curable When Caught Early

Here is the message that matters most: plague is curable with prompt antibiotics. The bacterium is susceptible to several inexpensive, widely available drugs, and patients who are treated early usually recover. What turns plague deadly today is not the microbe’s invincibility — it is delay.

The mainstays of treatment are:

A typical course runs about 10 to 14 days. Supportive care — intravenous fluids, oxygen, and intensive-care support for shock or respiratory failure — is often needed in severe septicemic and pneumonic cases.

For pneumonic plague, timing is everything. Antibiotics generally must begin within roughly 24 hours of the first symptoms to give the best chance of survival. That is why doctors treat first and confirm later when the suspicion is strong.

Protecting the exposed (post-exposure prophylaxis). People who have had close contact with someone with pneumonic plague, or who share a likely exposure, are given a preventive course of antibiotics — usually doxycycline or a fluoroquinolone for seven days — and watched for fever. Taken promptly, this preventive treatment is highly effective at stopping infection before it starts.

Prevention

Because Yersinia pestis lives permanently in wildlife, plague cannot be eradicated — but personal risk can be lowered dramatically with straightforward measures aimed at breaking the flea-and-rodent link:

There is currently no widely licensed human plague vaccine in general use; an older killed whole-cell vaccine has been discontinued, and newer subunit vaccines are still in development. Prevention therefore rests on flea and rodent control, avoiding sick animals, and fast recognition and treatment.

Plague as a Select Agent

Alongside its natural existence, Yersinia pestis carries a second, sober designation: it is classified as a Tier 1 Select Agent and a Category A bioterrorism agent — the highest-concern tier, shared with organisms such as anthrax and smallpox. The reason is specific: an intentional aerosol release of the bacterium could, in theory, cause an outbreak of primary pneumonic plague, the fast-moving, person-to-person form. A landmark public-health consensus statement published in JAMA in 2000 laid out how such a scenario would be recognized and managed.

It is worth being honest and factual about this without being alarmist. Plague has, in fact, been explored as a weapon in the past — most notoriously by Japan’s Unit 731, which dispersed plague-infected fleas during the Second World War — which is part of why it is studied and stockpiled against today. But for essentially everyone, plague is a naturally acquired, rare, animal-linked disease, not a security threat in daily life. The Select Agent designation mainly means that laboratories handle the bacterium under tight regulation, that public-health systems keep antibiotics and diagnostics ready, and that unusual clusters — particularly of pneumonic plague with no clear animal source — are investigated carefully. For an individual, the practical takeaways are unchanged: know the risk in endemic areas, avoid fleas and sick animals, and seek care fast.

The Honest Bottom Line

Plague earned its terrifying reputation in an age before antibiotics, when it truly was, for many, a death sentence. That age is over. Yersinia pestis has not changed — but our ability to treat it has, completely. Today plague is a curable bacterial infection for the great majority of patients who receive prompt antibiotics. The horror that remains is almost entirely in delay: an illness so rare that it is not suspected, a patient who waits too long, a diagnosis missed because no one thought of it.

So the practical message is calm and clear. If you live in or visit an area where plague circulates, protect yourself against fleas, keep rodents away from your home, and avoid handling sick or dead wild animals and free-roaming pets that hunt them. And if a sudden high fever with a painful swollen lymph node, or a rapidly worsening pneumonia, follows a possible exposure — seek medical care immediately, and mention the possibility of plague. Recognized early, plague is treatable. The disease that once emptied cities is, in the modern world, a race against time that medicine usually wins — provided the race begins in time.

Research Papers

  1. Prentice MB, Rahalison L. Plague. The Lancet. 2007;369(9568):1196–1207. doi:10.1016/S0140-6736(07)60566-2 — Authoritative clinical review of plague’s microbiology, three clinical forms, diagnosis, and treatment.
  2. Barbieri R, Signoli M, Chevé D, et al. Yersinia pestis: the Natural History of Plague. Clinical Microbiology Reviews. 2020;34(1):e00044-19. doi:10.1128/CMR.00044-19 — Comprehensive review tying the bacterium’s biology to the ecology of its rodent-and-flea reservoirs and human disease.
  3. Yang R. Plague: Recognition, Treatment, and Prevention. Journal of Clinical Microbiology. 2018;56(1):e01519-17. doi:10.1128/JCM.01519-17 — Practical overview of how plague is diagnosed in the laboratory, treated, and prevented.
  4. Nelson CA, Meaney-Delman D, Fleck-Derderian S, et al. Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response. MMWR Recommendations and Reports. 2021;70(3):1–27. doi:10.15585/mmwr.rr7003a1 — Current CDC treatment and post-exposure prophylaxis guidance, including drug choices and durations.
  5. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a Biological Weapon: Medical and Public Health Management. JAMA. 2000;283(17):2281–2290. doi:10.1001/jama.283.17.2281 — The landmark consensus statement on recognizing and managing a deliberate plague release.
  6. Pechous RD, Sivaraman V, Stasulli NM, et al. Pneumonic Plague: The Darker Side of Yersinia pestis. Trends in Microbiology. 2016;24(3):190–197. doi:10.1016/j.tim.2015.11.008 — Focused review of why the lung form is so rapid, lethal, and transmissible.
  7. Demeure CE, Dussurget O, Mas Fiol G, et al. Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics. Genes & Immunity. 2019;20(5):357–370. doi:10.1038/s41435-019-0065-0 — Modern synthesis of how the bacterium evades immunity, plus the state of vaccines and diagnostics.
  8. Butler T. Plague history: Yersin’s discovery of the causative bacterium in 1894. Clinical Microbiology and Infection. 2014;20(3):202–209. doi:10.1111/1469-0691.12540 — Historical account of the 1894 discovery and the century of progress in treatment and vaccines that followed.
  9. Wagner DM, Klunk J, Harbeck M, et al. Yersinia pestis and the Plague of Justinian 541–543 AD: a genomic analysis. The Lancet Infectious Diseases. 2014;14(4):319–326. doi:10.1016/S1473-3099(13)70323-2 — Ancient-DNA evidence confirming Y. pestis as the cause of the first pandemic.
  10. Bos KI, Schuenemann VJ, Golding GB, et al. A draft genome of Yersinia pestis from victims of the Black Death. Nature. 2011;478(7370):506–510. doi:10.1038/nature10549 — Reconstruction of the medieval Black Death genome from London plague-pit remains.
  11. Rasmussen S, Allentoft ME, Nielsen K, et al. Early Divergent Strains of Yersinia pestis in Eurasia 5,000 Years Ago. Cell. 2015;163(3):571–582. doi:10.1016/j.cell.2015.10.009 — Shows the bacterium infected humans in the Bronze Age, long before the recorded pandemics.

Back to Table of Contents

Connections

Back to Table of Contents